Skip to search formSkip to main contentSkip to account menu

4,4',6-trimethylangelicin

Known as: 4,4',6-TMA, 4,6,4'-trimethylangelicin, 2H-Furo(2,3-h)-1-benzopyran-2-one, 4,6,9-trimethyl-, (5Z,11alpha,13E,15S)- 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2014
2014
Cystic fibrosis transmembrane conductance regulator (CFTR) carrying the F508del mutation is retained in endoplasmic reticulum and… 
2011
2011
Chronic inflammatory response in the airway tract of patients affected by cystic fibrosis is characterized by an excessive… 
1996
1996
With the aim of obtaining new potential photochemotherapeutic agents, having increased antiproliferative activity and decreased… 
1993
1993
The capacity of some linear and angular furocoumarins to induce DNA‐protein cross‐links by UVA (320–400 nm) irradiation has been… 
1991
1991
Summary The incidence and clinical features of allergic contact and/or photocontact dermatitis due to psoralens were examined in… 
1984
1984
Abstract— 4,4',6‐Trimethylangelicin is a new monofunctional furocoumarin which appears to be a very promising potential agent for…